All webinars
Watch and listen to experts discuss developments in the field of aromatic L-amino acid decarboxylase (AADC) deficiency, presented across live and virtual platforms and summarized in infographics
Select from our webinar content below:
|
Get clinical insights into topics such as the common causes of AADC deficiency misdiagnosis, best practice approaches for differential diagnosis, current standards of care, and much more.
Eladocagene Exuparvovec is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to PTC Therapeutics at pharmacovigilance@ptcbio.com.Registration conditions differ internationally; always consult local prescribing information and/or Summary of Product Characteristics before prescribing any products.
MED-ALL-PTC-AADC-2500006 | September 2025
MED-ALL-AADC-2300013 | June 2025